» Articles » PMID: 35057041

Polysaccharide 3D Printing for Drug Delivery Applications

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Jan 21
PMID 35057041
Authors
Affiliations
Soon will be listed here.
Abstract

3D printing, or additive manufacturing, has gained considerable interest due to its versatility regarding design as well as in the large choice of materials. It is a powerful tool in the field of personalized pharmaceutical treatment, particularly crucial for pediatric and geriatric patients. Polysaccharides are abundant and inexpensive natural polymers, that are already widely used in the food industry and as excipients in pharmaceutical and cosmetic formulations. Due to their intrinsic properties, such as biocompatibility, biodegradability, non-immunogenicity, etc., polysaccharides are largely investigated as matrices for drug delivery. Although an increasing number of interesting reviews on additive manufacturing and drug delivery are being published, there is a gap concerning the printing of polysaccharides. In this article, we will review recent advances in the 3D printing of polysaccharides focused on drug delivery applications. Among the large family of polysaccharides, the present review will particularly focus on cellulose and cellulose derivatives, chitosan and sodium alginate, printed by fused deposition modeling and extrusion-based printing.

Citing Articles

Extrusion-Based 3D Printing of Pharmaceuticals-Evaluating Polymer (Sodium Alginate, HPC, HPMC)-Based Ink's Suitability by Investigating Rheology.

Rony F, Kimbell G, Serrano T, Clay D, Ilias S, Azad M Micromachines (Basel). 2025; 16(2).

PMID: 40047629 PMC: 11857113. DOI: 10.3390/mi16020163.


Evaluating Swellable Cross-Linked Biopolymer Impact on Ink Rheology and Mechanical Properties of Drug-Contained 3D-Printed Thin Film.

Rony F, Appiah J, Alawbali A, Clay D, Ilias S, Azad M Pharmaceutics. 2025; 17(2).

PMID: 40006550 PMC: 11858972. DOI: 10.3390/pharmaceutics17020183.


Soluble Fluorinated Cardo Copolyimide as an Effective Additive to Photopolymerizable Compositions Based on Di(meth)acrylates: Application for Highly Thermostable Primary Protective Coating of Silica Optical Fiber.

Sapozhnikov D, Melnik O, Chuchalov A, Kovylin R, Chesnokov S, Khanin D Int J Mol Sci. 2024; 25(10).

PMID: 38791532 PMC: 11122490. DOI: 10.3390/ijms25105494.


Advances in tissue engineering and biofabrication for skin modeling.

Wistner S, Rashad L, Slaughter G Bioprinting. 2024; 35.

PMID: 38645432 PMC: 11031264. DOI: 10.1016/j.bprint.2023.e00306.


3D-Printed Chitosan-Based Scaffolds with Extract for Dental Applications.

Paczkowska-Walendowska M, Koumentakou I, Lazaridou M, Bikiaris D, Miklaszewski A, Plech T Pharmaceutics. 2024; 16(3).

PMID: 38543253 PMC: 10974774. DOI: 10.3390/pharmaceutics16030359.


References
1.
Su L, Feng Y, Wei K, Xu X, Liu R, Chen G . Carbohydrate-Based Macromolecular Biomaterials. Chem Rev. 2021; 121(18):10950-11029. DOI: 10.1021/acs.chemrev.0c01338. View

2.
Bandiera A, Catanzano O, Bertoncin P, Bergonzi C, Bettini R, Elviri L . 3D-printed scaffold composites for the stimuli-induced local delivery of bioactive adjuncts. Biotechnol Appl Biochem. 2021; 69(5):1793-1804. PMC: 9786899. DOI: 10.1002/bab.2245. View

3.
Unagolla J, Jayasuriya A . Hydrogel-based 3D bioprinting: A comprehensive review on cell-laden hydrogels, bioink formulations, and future perspectives. Appl Mater Today. 2020; 18. PMC: 7414424. DOI: 10.1016/j.apmt.2019.100479. View

4.
Won J, Kim J, Gao G, Kim J, Jang J, Park Y . 3D printing of drug-loaded multi-shell rods for local delivery of bevacizumab and dexamethasone: A synergetic therapy for retinal vascular diseases. Acta Biomater. 2020; 116:174-185. DOI: 10.1016/j.actbio.2020.09.015. View

5.
Chawla S, Midha S, Sharma A, Ghosh S . Silk-Based Bioinks for 3D Bioprinting. Adv Healthc Mater. 2018; 7(8):e1701204. DOI: 10.1002/adhm.201701204. View